Eculizumab: A Complementary addition to existing long-term therapies for myasthenia gravis.

Muscle Nerve

Division of Neuromuscular Medicine, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, 165 Cambridge Street, Suite 820, Boston, Massachusetts, 02114, USA.

Published: July 2019

Download full-text PDF

Source
http://dx.doi.org/10.1002/mus.26512DOI Listing

Publication Analysis

Top Keywords

eculizumab complementary
4
complementary addition
4
addition existing
4
existing long-term
4
long-term therapies
4
therapies myasthenia
4
myasthenia gravis
4
eculizumab
1
addition
1
existing
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!